Annual Statement of Changes in Beneficial Ownership (5)

FORM 5

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ] Form 3 Holdings Reported
[ X ] Form 4 Transactions Reported

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response... 1.0

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Kariv Tomer	2. Issuer Name and Ticker or Trading Symbol Arno Therapeutics, Inc [ARNI]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 200 ROUTE 31 NORTH, SUITE 104	3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) 12/31/2014
(Street) FLEMINGTON, NJ 08822 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form Filed by One Reporting Person ___ Form Filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)	4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock							639459	I	By Pontifax (Cayman) II L.P. ⁽¹⁾
Common Stock							481680	I	By Pontifax (Israel) II L.P. ⁽¹⁾
Common stock							186982	I	By Pontifax (Israel) II - Individual Investors L.P. ⁽¹⁾

*Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (MM/DD/YYYY)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽²⁾		203682	10/29/2013	10/31/2014	Common Stock	203682	$0	0	I	Pontifax (Cayman) II L.P. ⁽¹⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽²⁾	203682		10/29/2013	1/31/2015	Common Stock	203682	$0	203682	I	Pontifax (Cayman) II L.P. ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽²⁾		203682	10/29/2013	10/31/2014	Common Stock	203682	$0	0	I	Pontifax (Cayman) II L.P. ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽²⁾	203682		10/29/2013	1/31/2015	Common Stock	203682	$0	203682	I	Pontifax (Cayman) II L.P. ⁽¹⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽²⁾		153426	10/29/2013	10/31/2014	Common Stock	153426	$0	0	I	Pontifax (Israel) II L.P. ⁽¹⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽²⁾	153426		10/29/2013	1/31/2015	Common Stock	153426	$0	153426	I	Pontifax (Israel) II L.P. ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽²⁾		153426	10/29/2013	10/31/2014	Common stock	153426	$0	0	I	Pontifax (Israel) II L.P. ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽²⁾	153426		10/29/2013	1/31/2015	Common Stock	153426	$0	153426	I	Pontifax (Israel) II L.P. ⁽¹⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽²⁾		59558	10/29/2013	10/31/2014	Common Stock	59558	$0	0	I	Pontifax (Israel) II - Individual Investors L.P. ⁽¹⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽²⁾	59558		10/29/2013	1/31/2015	Common Stock	59558	$0	59558	I	Pontifax (Israel) II - Individual Investors L.P. ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽²⁾		59558	10/29/2013	10/31/2014	Common Stock	59558	$0	0	I	Pontifax (Israel) II - Individual Investors L.P. ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽²⁾	59558		10/29/2013	1/31/2015	Common Stock	59558	$0	59558	I	Pontifax (Israel) II - Individual Investors L.P. ⁽¹⁾

Explanation of Responses:
( 1)	The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
( 2)	The two reported transactions resulted from the Issuer's unilateral extension of the expiration date of two outstanding warrants from 10/31/14 to 1/31/15. Such extension resulted in the deemed cancellation of the "originally" issued old warrant and the issuance of a replacement warrant. The Series B warrant was originally granted on 11/26/12 and the Series E warrant was originally granted on 10/29/13.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Kariv Tomer 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON, NJ 08822	X

Signatures
/s/ Christopher J. Melsha as Attorney-in-Fact for Tomer Kariv pursuant to Power of Attorney previously filed.		2/17/2015
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.